Results 81 to 90 of about 43,549 (203)

A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice. [PDF]

open access: yes, 2016
Choroideremia (CHM) is a rare X-linked disease leading to progressive retinal degeneration resulting in blindness. The disorder is caused by mutations in the CHM gene encoding REP-1 protein, an essential component of the Rab geranylgeranyltransferase ...
Avila-Fernandez, A.   +20 more
core   +3 more sources

Artificial lipidation of proteins and peptides: from mechanism to clinical applications

open access: yesThe FEBS Journal, Volume 293, Issue 5, Page 1269-1284, March 2026.
Artificial lipidation transforms protein and peptide therapeutics by attaching fatty acid chains through reversible or permanent chemical strategies. This biomimetic approach delivers four key therapeutic advantages: extended circulation times (enabling weekly instead of daily dosing), alternative administration routes including oral delivery, precise ...
Jiaming Mu, Emily Vong, Sheiliza Carmali
wiley   +1 more source

Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency

open access: yesFrontiers in Immunology, 2019
The rare autoinflammatory disease mevalonate kinase deficiency (MKD, which includes HIDS and mevalonic aciduria) is caused by recessive, pathogenic variants in the MVK gene encoding mevalonate kinase.
Marcia A. Munoz   +10 more
doaj   +1 more source

KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models [PDF]

open access: yes, 2017
BACKGROUND: In non-small cell lung cancer (NSCLC) KRAS-mutant status is a negative prognostic and predictive factor. Nitrogen-containing bisphosphonates inhibit prenylation of small G-proteins (e.g.
Barone   +44 more
core   +1 more source

Protein prenylation in spinach chloroplasts [PDF]

open access: yesProceedings of the National Academy of Sciences, 1999
Protein prenylation in plants was studied by in vivo metabolic 3 H-mevalonate labeling in combination with a range of protein synthesis inhibitors. In spinach cotyledons, this posttranslational protein modification was found to be divided into two categories, one representing the conventional
I, Parmryd, B, Andersson, G, Dallner
openaire   +2 more sources

Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum [PDF]

open access: yes, 2013
The antimalarial agent fosmidomycin is a validated inhibitor of the nonmevalonate isoprenoid biosynthesis (methylerythritol 4-phosphate [MEP]) pathway in the malaria parasite, Plasmodium falciparum.
Hodge, Dana   +4 more
core   +2 more sources

Rosuvastatin in Combination With Bortezomib Promotes Osteogenesis in Myeloma Bone Disease by Inhibiting the Secretion of CCL3

open access: yeseJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT Background Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM) and a primary cause of disability in affected patients. Its pathogenesis is driven by an imbalance in bone remodeling, largely attributed to the overexpression of C‐C motif chemokine ligand 3 (CCL3). While both bortezomib and statins have been reported
Fujun Qu   +6 more
wiley   +1 more source

Prenylates Xanthones from Garcinia xanthochymus.

open access: yesChemInform, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
Wisinee, Chanmahasathien   +6 more
openaire   +3 more sources

Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells [PDF]

open access: yes, 2017
Only 40% of patients with advanced ovarian cancer survive more than 5 years. We have previously shown that pitavastatin induces regression of ovarian cancer xenografts in mice.
Abdullah, MI, Abed, MN, Richardson, A
core   +1 more source

Home - About - Disclaimer - Privacy